Cargando…

Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study

BACKGROUND: Intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19), have a high risk of developing bloodstream infections (BSIs). However, the characteristics of and risk factors for BSIs in these patients remain unclear. OBJECTIVE: We aimed to identify prevalent causative patho...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartoszewicz, Mateusz, Czaban, Sławomir Lech, Bartoszewicz, Klaudia, Kuźmiuk, Damian, Ładny, Jerzy Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590042/
https://www.ncbi.nlm.nih.gov/pubmed/37869469
http://dx.doi.org/10.1177/20499361231207178
_version_ 1785123915338612736
author Bartoszewicz, Mateusz
Czaban, Sławomir Lech
Bartoszewicz, Klaudia
Kuźmiuk, Damian
Ładny, Jerzy Robert
author_facet Bartoszewicz, Mateusz
Czaban, Sławomir Lech
Bartoszewicz, Klaudia
Kuźmiuk, Damian
Ładny, Jerzy Robert
author_sort Bartoszewicz, Mateusz
collection PubMed
description BACKGROUND: Intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19), have a high risk of developing bloodstream infections (BSIs). However, the characteristics of and risk factors for BSIs in these patients remain unclear. OBJECTIVE: We aimed to identify prevalent causative pathogens of BSI and related factors in critically ill patients with COVID-19. DESIGN: This was a single-center, retrospective cohort study. METHODS: We analyzed the clinical characteristics and outcomes of 201 ICU patients with COVID-19. Logistic regression analysis was conducted to identify factors associated with BSI occurrence. Furthermore, we identified the primary causative pathogens of BSIs. The study outcomes were death or ICU discharge. RESULTS: Among the 201 included patients, 43 (21.4%) patients developed BSI. The mortality rate was non-significantly higher in the BSI group than in the BSI group (65.1% versus 58.9%, p = 0.487). There were significant between-group differences in the obesity prevalence and sex distribution, but not corticosteroid usage. BSI occurrence was significantly associated with duration of mechanical ventilation (MV), presence of ventilator-associated pneumonia, use of neuromuscular blocking agents, length of stay in ICU (ICU LOS), high body mass index (BMI), and male sex. The main causative pathogens were Klebsiella pneumoniae, Acinetobacter baumannii, and Enterococcus faecalis. Multi-drug-resistant pathogens were found in 87% of cases. Regardless of the origin, the common risk factors for BSI were ICU LOS and MV duration. All BSIs were acquired within the hospital setting, with ≈60% of the cases being primary BSIs. A small proportion of the BSI cases were catheter-related (four cases, 6.2%). Ventilator-associated pneumonia and urinary tract infections were present in 25% and 9.4% of the BSI cases, respectively. On average, the first positive blood culture appeared ≈11.4 (±9.7) days after ICU admission. CONCLUSION: Elucidating the risk factors for and common pathogens of BSI can inform prompt management and prevention of BSIs.
format Online
Article
Text
id pubmed-10590042
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-105900422023-10-22 Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study Bartoszewicz, Mateusz Czaban, Sławomir Lech Bartoszewicz, Klaudia Kuźmiuk, Damian Ładny, Jerzy Robert Ther Adv Infect Dis Original Research BACKGROUND: Intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19), have a high risk of developing bloodstream infections (BSIs). However, the characteristics of and risk factors for BSIs in these patients remain unclear. OBJECTIVE: We aimed to identify prevalent causative pathogens of BSI and related factors in critically ill patients with COVID-19. DESIGN: This was a single-center, retrospective cohort study. METHODS: We analyzed the clinical characteristics and outcomes of 201 ICU patients with COVID-19. Logistic regression analysis was conducted to identify factors associated with BSI occurrence. Furthermore, we identified the primary causative pathogens of BSIs. The study outcomes were death or ICU discharge. RESULTS: Among the 201 included patients, 43 (21.4%) patients developed BSI. The mortality rate was non-significantly higher in the BSI group than in the BSI group (65.1% versus 58.9%, p = 0.487). There were significant between-group differences in the obesity prevalence and sex distribution, but not corticosteroid usage. BSI occurrence was significantly associated with duration of mechanical ventilation (MV), presence of ventilator-associated pneumonia, use of neuromuscular blocking agents, length of stay in ICU (ICU LOS), high body mass index (BMI), and male sex. The main causative pathogens were Klebsiella pneumoniae, Acinetobacter baumannii, and Enterococcus faecalis. Multi-drug-resistant pathogens were found in 87% of cases. Regardless of the origin, the common risk factors for BSI were ICU LOS and MV duration. All BSIs were acquired within the hospital setting, with ≈60% of the cases being primary BSIs. A small proportion of the BSI cases were catheter-related (four cases, 6.2%). Ventilator-associated pneumonia and urinary tract infections were present in 25% and 9.4% of the BSI cases, respectively. On average, the first positive blood culture appeared ≈11.4 (±9.7) days after ICU admission. CONCLUSION: Elucidating the risk factors for and common pathogens of BSI can inform prompt management and prevention of BSIs. SAGE Publications 2023-10-20 /pmc/articles/PMC10590042/ /pubmed/37869469 http://dx.doi.org/10.1177/20499361231207178 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Bartoszewicz, Mateusz
Czaban, Sławomir Lech
Bartoszewicz, Klaudia
Kuźmiuk, Damian
Ładny, Jerzy Robert
Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study
title Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study
title_full Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study
title_fullStr Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study
title_full_unstemmed Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study
title_short Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study
title_sort bacterial bloodstream infection in critically ill patients with covid-19: a retrospective cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590042/
https://www.ncbi.nlm.nih.gov/pubmed/37869469
http://dx.doi.org/10.1177/20499361231207178
work_keys_str_mv AT bartoszewiczmateusz bacterialbloodstreaminfectionincriticallyillpatientswithcovid19aretrospectivecohortstudy
AT czabansławomirlech bacterialbloodstreaminfectionincriticallyillpatientswithcovid19aretrospectivecohortstudy
AT bartoszewiczklaudia bacterialbloodstreaminfectionincriticallyillpatientswithcovid19aretrospectivecohortstudy
AT kuzmiukdamian bacterialbloodstreaminfectionincriticallyillpatientswithcovid19aretrospectivecohortstudy
AT ładnyjerzyrobert bacterialbloodstreaminfectionincriticallyillpatientswithcovid19aretrospectivecohortstudy